Halozyme Therapeutics (HALO) Non-Current Assets (2010 - 2026)
Halozyme Therapeutics (HALO) reported Non-Current Assets of $1.64 billion for Q2 2026, up 76.6% from $931.23 million a year earlier but down 1.5% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics posted Non-Current Assets of $1.7 billion, up 73.8% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of 132.2% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $978.14 million in FY2024 (-0.9%), $986.85 million in FY2023 (-10.5%), $1.1 billion in FY2022 (+518.9%) and $178.14 million in FY2021 (+608.0%).
- Five-year quarterly Non-Current Assets spans a low of $168.12 million in Q3 2021 and a high of $1.7 billion in Q4 2025.
- Year over year, Non-Current Assets has now increased in each of the last three quarters, with growth averaging 25.9% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q3 2022 (growth of 620.5%); the low point was Q3 2023 (a decline of 16.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.67 billion (Q1 2026), $1.7 billion (Q4 2025) and $892.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 1.64 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Bn |
| Mar 31, 2026 | 1.67 Bn |
| Dec 31, 2025 | 1.70 Bn |
| Sep 30, 2025 | 892.48 Mn |
| Jun 30, 2025 | 931.23 Mn |
| Mar 31, 2025 | 934.50 Mn |
| Dec 31, 2024 | 978.14 Mn |
| Sep 30, 2024 | 991.05 Mn |
| Jun 30, 2024 | 981.66 Mn |
| Mar 31, 2024 | 967.94 Mn |
| Dec 31, 2023 | 986.85 Mn |
| Sep 30, 2023 | 1.01 Bn |
| Jun 30, 2023 | 1.04 Bn |
| Mar 31, 2023 | 1.08 Bn |
| Dec 31, 2022 | 1.10 Bn |
| Sep 30, 2022 | 1.21 Bn |
| Jun 30, 2022 | 1.24 Bn |
| Mar 31, 2022 | 173.56 Mn |
| Dec 31, 2021 | 178.14 Mn |
| Sep 30, 2021 | 168.12 Mn |
API Access
Halozyme Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();